X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs IPCA LABS - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD IPCA LABS ALEMBIC LTD/
IPCA LABS
 
P/E (TTM) x 122.8 44.9 273.4% View Chart
P/BV x 4.6 3.4 132.4% View Chart
Dividend Yield % 0.2 0.1 164.9%  

Financials

 ALEMBIC LTD   IPCA LABS
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
IPCA LABS
Mar-17
ALEMBIC LTD/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs53643 8.2%   
Low Rs29503 5.8%   
Sales per share (Unadj.) Rs4.7254.4 1.9%  
Earnings per share (Unadj.) Rs8.816.1 54.6%  
Cash flow per share (Unadj.) Rs9.029.8 30.2%  
Dividends per share (Unadj.) Rs0.151.00 15.0%  
Dividend yield (eoy) %0.40.2 209.3%  
Book value per share (Unadj.) Rs27.7194.6 14.3%  
Shares outstanding (eoy) m267.03126.20 211.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.72.3 386.2%   
Avg P/E ratio x4.735.7 13.1%  
P/CF ratio (eoy) x4.619.2 23.7%  
Price / Book Value ratio x1.52.9 50.3%  
Dividend payout %1.76.2 27.5%   
Avg Mkt Cap Rs m10,96272,300 15.2%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m2386,960 3.4%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m1,26032,106 3.9%  
Other income Rs m264226 116.9%   
Total revenues Rs m1,52432,332 4.7%   
Gross profit Rs m834,448 1.9%  
Depreciation Rs m611,730 3.6%   
Interest Rs m0241 0.1%   
Profit before tax Rs m2852,703 10.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6675 0.9%   
Profit after tax Rs m2,3432,028 115.5%  
Gross profit margin %6.613.9 47.4%  
Effective tax rate %2.125.0 8.6%   
Net profit margin %185.96.3 2,943.0%  
BALANCE SHEET DATA
Current assets Rs m1,68917,340 9.7%   
Current liabilities Rs m4869,559 5.1%   
Net working cap to sales %95.424.2 393.8%  
Current ratio x3.51.8 191.5%  
Inventory Days Days217100 216.3%  
Debtors Days Days8157 142.5%  
Net fixed assets Rs m1,62420,779 7.8%   
Share capital Rs m534252 211.6%   
"Free" reserves Rs m5,96024,499 24.3%   
Net worth Rs m7,40424,553 30.2%   
Long term debt Rs m1043,517 3.0%   
Total assets Rs m8,01039,595 20.2%  
Interest coverage x950.712.2 7,775.8%   
Debt to equity ratio x00.1 9.8%  
Sales to assets ratio x0.20.8 19.4%   
Return on assets %29.35.7 510.5%  
Return on equity %31.68.3 383.1%  
Return on capital %31.310.5 298.3%  
Exports to sales %2.948.6 6.1%   
Imports to sales %28.914.2 202.7%   
Exports (fob) Rs m3715,617 0.2%   
Imports (cif) Rs m3644,571 8.0%   
Fx inflow Rs m3715,617 0.2%   
Fx outflow Rs m3655,828 6.3%   
Net fx Rs m-3289,790 -3.3%   
CASH FLOW
From Operations Rs m3462,764 12.5%  
From Investments Rs m-48-1,432 3.3%  
From Financial Activity Rs m-301-1,591 18.9%  
Net Cashflow Rs m-3-259 1.2%  

Share Holding

Indian Promoters % 64.0 45.9 139.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 11.4 1.8%  
FIIs % 9.7 25.3 38.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.4 150.0%  
Shareholders   54,701 36,892 148.3%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   CIPLA  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; PSU & Energy Stocks Decline(01:30 pm)

Indian share markets continued to trade in red during the noon session weak Asian markets. PSU stocks and energy stocks are witnessing majority of the selling activity.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 22, 2018 01:49 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS